Kara Wegermann

1000 total citations
35 papers, 505 citations indexed

About

Kara Wegermann is a scholar working on Epidemiology, Hepatology and Molecular Biology. According to data from OpenAlex, Kara Wegermann has authored 35 papers receiving a total of 505 indexed citations (citations by other indexed papers that have themselves been cited), including 25 papers in Epidemiology, 17 papers in Hepatology and 6 papers in Molecular Biology. Recurrent topics in Kara Wegermann's work include Liver Disease Diagnosis and Treatment (22 papers), Liver Disease and Transplantation (13 papers) and Metabolomics and Mass Spectrometry Studies (4 papers). Kara Wegermann is often cited by papers focused on Liver Disease Diagnosis and Treatment (22 papers), Liver Disease and Transplantation (13 papers) and Metabolomics and Mass Spectrometry Studies (4 papers). Kara Wegermann collaborates with scholars based in United States, Canada and Singapore. Kara Wegermann's co-authors include Anna Mae Diehl, Cynthia A. Moylan, Yuval A. Patel, Julius Wilder, Manal F. Abdelmalek, Andrew J. Muir, Donna Niedzwiecki, Alice Parish, Ziad F. Gellad and Marat Fudim and has published in prestigious journals such as Gastroenterology, Journal of the American College of Cardiology and PLoS ONE.

In The Last Decade

Kara Wegermann

28 papers receiving 497 citations

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name h Career Trend Papers Cites
Kara Wegermann United States 14 277 167 83 79 77 35 505
Diego Martínez‐Urbistondo Spain 12 127 0.5× 73 0.4× 70 0.8× 47 0.6× 63 0.8× 40 498
Rakesh Biswas India 12 269 1.0× 172 1.0× 160 1.9× 29 0.4× 37 0.5× 78 588
Seon Cho South Korea 12 191 0.7× 69 0.4× 41 0.5× 37 0.5× 24 0.3× 43 428
Smruti R. Mohanty United States 11 420 1.5× 235 1.4× 141 1.7× 37 0.5× 15 0.2× 38 665
Thomas Shin United States 14 275 1.0× 99 0.6× 221 2.7× 58 0.7× 57 0.7× 38 742
Nicola Pugliese Italy 13 206 0.7× 118 0.7× 69 0.8× 20 0.3× 21 0.3× 58 573
Anuradha Supun Dassanayake Sri Lanka 15 446 1.6× 245 1.5× 157 1.9× 67 0.8× 49 0.6× 49 725
Peter Jarčuška Slovakia 18 490 1.8× 432 2.6× 159 1.9× 30 0.4× 34 0.4× 82 915
Martin Janíčko Slovakia 14 391 1.4× 347 2.1× 126 1.5× 29 0.4× 24 0.3× 60 638
Michael C. Doherty United States 11 328 1.2× 180 1.1× 159 1.9× 41 0.5× 45 0.6× 14 553

Countries citing papers authored by Kara Wegermann

Since Specialization
Citations

This map shows the geographic impact of Kara Wegermann's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Kara Wegermann with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Kara Wegermann more than expected).

Fields of papers citing papers by Kara Wegermann

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Kara Wegermann. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Kara Wegermann. The network helps show where Kara Wegermann may publish in the future.

Co-authorship network of co-authors of Kara Wegermann

This figure shows the co-authorship network connecting the top 25 collaborators of Kara Wegermann. A scholar is included among the top collaborators of Kara Wegermann based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Kara Wegermann. Kara Wegermann is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

20 of 20 papers shown
1.
Javaid, Syed Sarmad, Amreen Dinani, Kara Wegermann, et al.. (2025). The Basics of Metabolic Dysfunction–Associated Steatotic Liver Disease for Cardiologists. Journal of the American College of Cardiology. 86(20). 1861–1884.
2.
Wegermann, Kara, Chia‐Yu Chu, Nhu Thao Nguyen Galván, et al.. (2025). Beyond the HIV Organ Policy Equity Act: Roadmap to expanding kidney and liver transplants for people with human immunodeficiency virus utilizing grafts from donors with human immunodeficiency virus. American Journal of Transplantation. 25(10). 2057–2066. 1 indexed citations
3.
Wegermann, Kara, Fouad Chouairi, Georgia Sofia Karachaliou, et al.. (2025). Incident Heart Failure is Common and Underrecognized in Patients with Biopsy-Proven Metabolic Dysfunction-Associated Steatotic Liver Disease. European Journal of Heart Failure. 27(11). 2041–2048. 1 indexed citations
4.
Moylan, Cynthia A., et al.. (2024). Racial and ethnic disparities in metabolic dysfunction-associated steatotic liver disease. 4(2). 5 indexed citations
5.
Dickinson, Anne M., et al.. (2024). S4259 A Case of Herpes Simplex Virus Hepatitis in Patient With SLE on Belimumab. The American Journal of Gastroenterology. 119(10S). S2742–S2742.
6.
7.
Wegermann, Kara, Anna Mae Diehl, & Cynthia A. Moylan. (2023). Challenges and barriers in hepatocellular carcinoma (HCC) surveillance for patients with non-alcoholic fatty liver disease (NAFLD). Hepatoma Research. 9. 11–11. 3 indexed citations
8.
Wegermann, Kara, Marat Fudim, Ricardo Henao, et al.. (2023). Serum Metabolites Are Associated With HFpEF in Biopsy‐Proven Nonalcoholic Fatty Liver Disease. Journal of the American Heart Association. 12(14). e029873–e029873. 5 indexed citations
9.
Chung, Sunny, Matthew Phelan, Benjamin A. Goldstein, et al.. (2021). S1224 Computable Phenotypes for NAFLD and NASH Identify Patients with Significant Comorbidities yet Most Remain Undiagnosed. The American Journal of Gastroenterology. 116(1). S564–S564.
10.
Peters, Anthony E., Ambarish Pandey, Colby Ayers, et al.. (2021). Association of Liver Fibrosis Risk Scores with Clinical Outcomes in Patients with Heart Failure with Preserved Ejection Fraction: Findings from TOPCAT. ESC Heart Failure. 8(2). 842–848. 41 indexed citations
11.
Wegermann, Kara, Yuval A. Patel, & Julius Wilder. (2021). Health Equity and Telemedicine in Gastroenterology and Hepatology. Clinical Gastroenterology and Hepatology. 19(8). 1516–1519. 14 indexed citations
12.
Salah, Husam M., Ambarish Pandey, A. E. Soloveva, et al.. (2021). Relationship of Nonalcoholic Fatty Liver Disease and Heart Failure With Preserved Ejection Fraction. JACC Basic to Translational Science. 6(11). 918–932. 66 indexed citations
13.
Wegermann, Kara, Melanie E. Garrett, Jiayin Zheng, et al.. (2021). Sex and Menopause Modify the Effect of Single Nucleotide Polymorphism Genotypes on Fibrosis in NAFLD. Hepatology Communications. 5(4). 598–607. 19 indexed citations
14.
Wegermann, Kara, Jeongeun Hyun, & Anna Mae Diehl. (2021). Molecular Mechanisms Linking Nonalcoholic Steatohepatitis to Cancer. Clinical Liver Disease. 17(1). 6–10. 15 indexed citations
15.
Adeniji, Nia, Elizabeth S. Aby, Ponni Perumalswami, et al.. (2020). PREDICTORS OF OUTCOMES OF COVID-19 IN PATIENTS WITH CHRONIC LIVER DISEASE: US MULTI-CENTER STUDY. Hepatology. 72. 1 indexed citations
16.
Wegermann, Kara, et al.. (2020). Successful banding of nodular gastric antral vascular ectasia in patients with refractory anemia. Gastrointestinal Endoscopy. 92(2). 422–423. 1 indexed citations
17.
Sullivan, Brian A., et al.. (2020). Standardizing inpatient colonoscopy preparations improves quality and provider satisfaction. International Journal of Health Care Quality Assurance. 33(3). 277–287. 3 indexed citations
18.
Wegermann, Kara, Anna Mae Diehl, & Cynthia A. Moylan. (2018). Disease pathways and molecular mechanisms of nonalcoholic steatohepatitis. Clinical Liver Disease. 11(4). 87–91. 9 indexed citations
19.
20.
Seraj, Siamak M., et al.. (2017). Hospital readmissions in decompensated cirrhotics: Factors pointing toward a prevention strategy. World Journal of Gastroenterology. 23(37). 6868–6876. 39 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Breakdown of academic impact, for papers by Diego Martínez‐Urbistondo Breakdown of academic impact, for papers by Rakesh Biswas Breakdown of academic impact, for papers by Seon Cho Breakdown of academic impact, for papers by Smruti R. Mohanty Breakdown of academic impact, for papers by Thomas Shin Breakdown of academic impact, for papers by Nicola Pugliese Breakdown of academic impact, for papers by Anuradha Supun Dassanayake Breakdown of academic impact, for papers by Peter Jarčuška Breakdown of academic impact, for papers by Martin Janíčko Breakdown of academic impact, for papers by Michael C. Doherty
Rankless by CCL
2026